2-Hydroxypropyl-beta-cyclodextrin Treatment Does Not Induce Atherosclerotic Lesion Regression in Western-Type Diet-Fed Apolipoprotein E Knockout Mice
2-Hydroxypropyl-beta-cyclodextrin (2HPβCD) is able to bind and solubilize unesterified cholesterol and may therefore be able to reverse the deposition of cholesterol in macrophages within the aortic vessel wall, a hallmark of atherosclerotic cardiovascular disease. However, conflicting results regar...
Main Authors: | Olga S.C. Snip, Menno Hoekstra, Yiheng Zhang, Janine J. Geerling, Miranda Van Eck |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/9/1205 |
Similar Items
-
Comparison of the capacity of β-cyclodextrin derivatives and cyclophanes to shuttle cholesterol between cells and serum lipoproteins
by: Aimee E. Christian, et al.
Published: (1999-08-01) -
Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of preβ-high density lipoprotein to α-high density lipoprotein
by: Dmitri Sviridov, et al.
Published: (2000-11-01) -
2-Hydroxypropyl-β-cyclodextrin (HPβCD) as a Potential Therapeutic Agent for Breast Cancer
by: Sourav Taru Saha, et al.
Published: (2023-05-01) -
The recycling of apolipoprotein E in macrophages
by: Alyssa H. Hasty, et al.
Published: (2005-07-01) -
Adenine-Induced Nephropathy Reduces Atherosclerosis in <i>ApoE</i> Knockout Mice
by: Laeticia Scherler, et al.
Published: (2022-08-01)